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ABSTRACT 
 
In vitro three-dimensional human skin models are an innovative alternative to evaluate 
cytotoxicity and phototoxicity in the cosmetic industry. The aim of this study was to use 
a skin model to evaluate the potential toxicity of sunscreen formulations with or without 
exposure to UV radiation. In addition, the toxicity of these formulations was evaluated 
after exposure to photodegradation. The results showed toxicity with all 
formulations/conditions tested, including the control formulation, compared to PBS. 
Cell viability of photodegraded formulations - prior to the phototoxicity radiation 
process - was higher, indicating that some formulation components were degraded into 
products with reduced toxicity. The results also indicated that avobenzone was more 
unstable/toxic than octyl p-methoxycinnamate under the same test conditions. The 
sunscreens and their formulations were shown to be toxic to skin model cells to some 
extent, even when not exposed to UV irradiation; however the biological role of this 
toxicity is unclear. This result shows the importance of testing sunscreen formulations 
in real in-use conditions. Finally, since we used an in vitro assay based on a human cell 
model, this non-invasive technique represents a suitable alternative to animal models for 
phototoxicity tests in general and could have application in screening new sunscreen 
products.  
 
Keywords:  
Three-dimensional human skin model, toxicity, phototoxicity, photoprotectors, UV-
induced cell damage, Neutral Red. 
 
Abbreviations:  
Octyl p-methoxycinnamate (OMC), avobenzone (AVB), Neutral Red (NR), solubilizing 
solution (SS), hematoxylin-eosin (HE). 
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1. Introduction 
 
In the twenty-first century, it is becoming increasingly important to develop in 
vitro alternatives to animal testing. Three-dimensional human skin models or tissue-
engineered constructs are adaptable and powerful research tools with numerous 
applications, such as the study of cancer, pigmentation and toxicity. In particular, many 
different techniques have been proposed to assess the photo- and cytotoxicity of 
potentially irritant chemicals such as sunscreens in a parallel development with the 
reduction in the number of animals used for marketing approval of these substances 
(Fernandez et al., 2012; Ponec, 2002).  
In this context, in vitro phototoxicity tests that are based on possible toxic 
reactions shown by cells or skin models after direct contact with specific substances, 
followed by exposure to UV sources, are extensively used. These allow the effects of 
different factors that may determine the levels of toxicity, such as the application 
volume, contact time with the model system, and the time of exposure to UV light to be 
discerned (OECD, 2004).
 
The burden on public health systems due to excessive exposure to sunlight 
represents the negative side of actively promoted lifestyles that keep individuals 
exposed to UV radiation. At the same time, however, the increasingly wide 
dissemination of information about the dangers of excessive exposure to solar radiation 
and the value of sunscreen use has led to a significant increase in the consumption of 
sunscreens. This increased sunscreen use, along with the need to evaluate new 
substances or products, makes it essential to develop robust in vitro toxicity tests.  
The active ingredients in an effective sunscreen formulation may be inorganic 
particles, organic molecules, or a combination of both. The particles absorb, reflect or 
scatter UV radiation. The organic compounds contain conjugated aromatic carboxylic 
groups and generally have an electron donating group such as an amine or methoxyl in 
the ortho position of the aromatic ring which absorbs radiation in different spectral 
regions (UVA or UVB) (Giokas et al., 2007). 
The sunscreen agent octyl p-methoxycinnamate (OMC) is currently the most 
frequently used sunscreen worldwide for protection from short wavelength UVB 
radiation. Avobenzone (AVB) is one of the agents that protects specifically against 
longer wavelength UVA radiation. AVB is very unstable and changes according 
to/depending on the formulation, which can lead to degradation by sunlight, placing its 
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phototoxicity protection in question (Gaspar et al., 2013). However, despite the 
extensively evaluated and well-known phototoxic effects of AVB and OMC, the 
increase or decrease of their toxicity when photodegraded and applied to human skin 
models has never been tested. 
In addition, regulatory and commercial agencies have stressed the importance of 
evaluating sunscreen formulation stability under in-use conditions, to ensure the 
efficacy and the safety of the final product (Klein and Palefsky, 2001). The aim of this 
study was to investigate the application of a human keratinocyte and fibroblast-based 
skin model using a de-epidermized dermal culture substrate as a tool to evaluate 
phototoxicity of photodegraded sunscreen formulations. The skin model was used to 
characterize the epidermal photoresponse to AVB and OMC sunscreen formulations 
after prior exposure to UV radiation that led to photodegradation. 
 
2. Materials and methods 
 
2.1. Human cell culture 
 
Human keratinocytes were obtained from skin fragments devoid of subcutaneous 
tissue by serial enzymatic cell separation using a 0.05% trypsin/ 0.02% EDTA solution 
(GIBCO-BRL Life Technologies, Rockville, MD, U.S.A.). The cells were plated on an 
irradiated 3T3 feeder layer in 75 cm
2
 culture flasks and cell culture was performed 
according to the methodology proposed by Rheinwald and Green (1975). The culture 
bottles were stored in a 5% CO2 incubator at 37°C.  
Human fibroblast suspensions were obtained by a similar procedure. 
Keratinocytes and fibroblasts were both enzymatically released and seeded onto 
prepared, de-epidermized, glycerol-preserved allodermis (Herson et al., 2001). 
 
2.2. Reconstruction of human skin containing a de-epidermized allodermis 
 
The reconstruction of the three-dimensional human skin model started by placing 
the de-epidermized allodermis, previously sterilized by 50 kGy, as described in Herson 
et al. (2001), into metal grids. Metal rings were fixed to limit the cell seed area. Onto 
that system ~500,000 cells/cm
2
 of each cell type (keratinocyte and fibroblast) were 
seeded and cultured for 21 days. After 24 h following inoculation, the metal rings were 
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carefully removed and more medium was added so that the culture was submerged. The 
first total medium change was performed after 48 h and then every third day for the next 
2 weeks. From the fourteenth to the twenty-first day of the experiments, culture medium 
was changed daily. The dermal fragments with proliferating keratinocytes were kept in 
submerged conditions for 7 days, allowing the cells to proliferate and for the last 14 
days the system were maintained under the air-liquid interface, required in order to 
obtain a fully differentiated epidermis with a stratum corneum layer (Herson et al., 
2001). The culture medium change was performed in order to keep the dermis in contact 
with the medium and the cells exposed to air, mimicking the in vivo skin. 
 
2.3 Sunscreen formulation 
 
The OMC (UVB) and AVB (UVA) filters were chosen to be tested in this skin 
model as they are the most commonly used cosmetic ingredients in commercial 
sunscreen products (Table 1). 
 
 
Table 1. Composition of the formulations used for the in vitro cytotoxicity and 
phototoxicity assays 
Ingredients BF (%) OMC (%) AVB (%) 
BHT 0.05 0.05 0.05 
Solution of Methylchoroisothiazolinone/ 
Methylisothiazolinone 
0.1 0.1 0.1 
EDTA disodium 2.0 2.0 2.0 
Glyceryl stearate 2.0 2.0 2.0 
Stearyl alcohol 2.5 2.5 2.5 
Cetearyl alcohol 3.0 3.0 3.0 
Peg 100 stearate/glyceryl/stearate 3.0 3.0 3.0 
Caprylyl methicone 4.0 4.0 4.0 
Glycerin 10 10 10 
C12–C15 alkyl benzoate 0.05 0.05 0.05 
Octyl Methoxycinnamate (OMC) - 10 - 
Butyl Methoxydibenzoylmethane (AVB) - - 4.0 
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Acqua 73.3 63.3 69.3 
 
A basic oil-in-water formulation (BF) was prepared with ingredients commonly 
used in the composition of commercial sunscreens. Formulation BFOMC and 
Formulation BFAVB were prepared by adding either the UVB filter OMC or the UVA 
filter AVB respectively to BF. 
Cosmotec (Brazil) supplied all formulation components, including the active 
photoprotective ingredients. All formulations cited above, with or without pre-
irradiation (i.e. degraded and non-degraded, respectively), were tested. 
The experimental design and protocol under which the different formulations 
were tested - in the presence and absence of radiation exposure - is shown in Figure 1. 
 
 
 
Fig. 1. Experimental design for the photodegradation test (UVA exposure) and 
phototoxicity tests (UVA exposure) of BF (basic formulation); OMC (basic formulation 
with OMC); AVB (basic formulation with AVB) in the conditions NT: no-treatment 
(not submitted to photostability chamber); I: irradiated; NI: not irradiated; C: covered 
with aluminum foil when submitted to photostability chamber; NC: not covered with 
aluminum foil and submitted to photostability chamber. 
 
2.4. Photostability chamber 
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The degradation process of all formulations tested, using 2 g of each sample 
spread as a thin film in Petri dishes (90 mm diameter), was conducted in a photostability 
chamber with UVA (with distributed spectrum between 320 nm and 400 nm, UV 
energy > 200w.h/m²) (Fotoestabilidade Farma 424 CF - Nova Ética) at 24.5 ºC for 60 
hours (exposure time obtained by actinometric procedure using a 2% w/v solution of 
quinine monohydrochloride dihydrate to achieve 200 watt hours/square meter as 
described in ICH Q1B guideline). The chamber used was in accordance with Q1B 
guide, published by the International Conference on Harmonization, and the light source 
corresponding to option 2 (ICH, 1996). UVA radiation was chosen to degrade the 
formulas (BF/NC, AVB/NC, OMC/NC), due to this type of radiation being normally 
present throughout the day. The control formulation samples that were not degraded 
(BF/C, AVB/C, OMC/C) were covered with aluminum foil and maintained in the 
photostability chamber for the same period under the same conditions as the degraded 
samples in order to provide the same environment. 
 
2.5. UV-vis spectrophotometry evaluation of formulations – degradation process 
 
The sunscreen formulations containing AVB 4% w/w or OMC 10% w/w were 
analyzed by UV-vis spectrophotometry. Samples of formulations that were taken from 
previously exposed or protected Petri dishes in the photostability chamber were 
weighed and dissolved in absolute ethanol at 2 mg/mL w/v (80 µg/mL of AVB or 200 
µg/mL of OMC). The solutions were diluted with absolute ethanol up to concentration 
of 0.04 µg/mL and analyzed by Thermo spectrophotometer (Evolution 201 - Thermo 
Scientific) at the range of 200 to 500 nm, using a quartz cuvette of 1.0 cm optical path. 
Formulation samples without sunscreens were submitted to the same analyses for 
comparison. Absolute ethanol was used as a blank. 
 
2.6. Phototoxicity chamber 
 
The simulation of sunlight by irradiation with UVA lamps (340 nm) was 
conducted in a phototoxicity testing chamber constructed in stainless steel frame and 
fitted with two 15 Watts Xenon lamps and a filter system, designed and built in 
accordance with the protocol 
©
ECVAM DB-ALM: INVITTOX protocol. This chamber 
provides UVA radiation at 1.7 mW/cm
2
 faithfully following the protocol OECD 
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Toxicity Guide 432, which proposes a radiation dose of 5 J/cm
2
 for testing the 
phototoxicity performance of chemicals in direct contact with the studied cells 
(ECVAM, 2008; OECD, 2004). Two reference substances - Bergamot oil (Citrus 
bergamia - Givaudan-Roche), as a positive control and Sodium Lauryl Sulfate as a 
negative control, both at a concentration range of 0.005 to 0.100 mg/mL, were used to 
validate the phototoxicity-testing chamber (Sufi, 2013). 
The multiwell plates containing the reconstructed skins (item 2.2) on grids were 
irradiated after topical application of ~ 2 mg/cm
2
 of formulations BF, OMC and AVB 
(uncovered: NC - photodegraded; or covered: C – non- photodegraded) as shown in Fig. 
1. These multiwell plates were divided in two groups; one that was subjected to UVA 
exposure and irradiated with 5 J/cm
2
 (BF/NC/I, BF/C/I, AVB/NC/I, AVB/C/I, 
OMC/NC/I, OMC/C/I), and a second group that was placed in the dark area of the 
chamber (BF/NC/NI, BF/C/NI, AVB/NC/NI, AVB/C/NI, OMC/NC/NI, OMC/C/NI) 
under the same conditions of temperature and time (75 minutes). Samples were rinsed 
after irradiation using PBS with Ca
2+ 
Mg
2+
, following the addition of fresh medium, 
maintained at 37°C and 5% CO2 overnight. 
The choice of this light source is a crucial factor in phototoxicity testing. 
Radiation in the UVA and visible regions is usually associated with phototoxic 
reactions in vivo (Lambert et al., 1996; Spielmann et al., 1994), whereas UVB is 
generally of less relevance but is highly cytotoxic (Tyrrell and Pidoux, 1987). 
 
2.7. Assessment of UV-induced cytotoxicity 
 
After 24 hours, Neutral Red (NR) solution was added to the human skin model, 
which was maintained at 37 °C and 5% CO2 for a further 3 hours. After that period, the 
NR solution was removed, the model washed and a solubilizing solution (SS) added to 
the wells. The multiwell plates were protected from light and agitated for 10 minutes on 
a plate shaker. After this time, the supernatant comprising the SS and the NR released 
by the cells was placed in 96-well multiwell plates to be read in a multiplate reader 
(Multiskan EX 355, Thermo Electron Corporation) at 540 nm. 
 
2.8. Statistical analysis 
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The data obtained from the phototoxicity test were processed by statistical 
analysis using one-way analysis of variance (ANOVA one-way, Duncan test, Tukey test 
and t- test) at a confidence range of 95%, so the changes were considered statistically 
significant for p < 0.05. 
 
2.9. Histological analysis 
 
Immediately after the phototoxicity experiments, the skin models were fixed in a 
formaldehyde solution 10%, buffered, dehydrated and embedded in histological 
paraffin. Histological sections (4 µm thickness) for each of the test groups were stained 
with hematoxylin-eosin (HE) to assess and compare the conditions of the structure of 
epidermal equivalents. 
 
The present study is part of a research project approved by the Research Ethics 
Committee of Faculdade de Saúde Pública of the Universidade de São Paulo – FSPUSP 
(CAAE 00583812.6.0000.5421). 
 
3. Results and Discussion 
 
Human skin models – a reliable way to assess toxicity UV skin damage 
 
Several in vitro cytotoxicity assays have been developed and performed by 
significant private and government agencies around the world. The Multicenter 
Evaluation of in vitro Cytotoxicity (MEIC) and the European Centre for the Validation 
of Alternative Methods (ECVAM) both recommend the Neutral Red uptake (NRU) 
assays, performed with mouse 3T3 fibroblast cells (3T3 NRU assay) or normal human 
keratinocytes cells (NHK NRU assay). These assays have been used to test a range of 
chemicals/pharmaceuticals already marketed and therefore tested in vivo, with mainly 
assays in monolayer culture, obtaining similar and reproducible laboratory results and 
making the assessment of in vitro cytotoxicity a feasible technique and also a source of 
highly reliable results (Clothier et al., 2013; Paris et al., 2005; Strickland et al., 2005). 
The 3T3 NRU phototoxicity assay is best suited for individual chemicals, and thus final 
formulations must be tested with 3D skin models, since solubility is not a limiting 
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factor. Further, chemicals are tested topically, and therefore testing conditions should 
resemble end user applications (Institute for in vitro Sciences, 2013). 
The establishment of three-dimensional skin models has addressed many previous 
limitations of toxicity tests. These skin models overcome important problems related to 
the use of animal models, such as strict ethical regulations, substantial costs and 
structural and biological inconsistencies (Adler et al., 2011; Ponec, 2002). 
In order to promote keratinocyte differentiation and epidermogenesis, 
construction of the skin models ends with an air-liquid interface, resulting in the 
formation of an epidermal layer that is histologically similar to native human skin, 
including the presence of a relatively normal stratum corneum (Fernandez et al., 2014; 
Kairuz et al., 2007; Topping et al., 2006). Due to the value of skin models for in vitro 
testing, we established in our laboratory a three-dimensional skin model as a tool to 
study wound healing and toxicity of extracts or formulations (Herson et al., 2001; 
Kamamoto et al., 2003). 
Here, we describe an additional application of our in-house skin model, to 
characterize the epidermal toxicity and photoresponse to a photodegraded sunscreen 
formulation. Since topical application of sunscreen formulations on these models 
mimics real human in vivo conditions, they are suitable for evaluating sunscreens in 
response to UV radiation. In addition, the use of UVA and UVB specific filters allowed 
the assessment of damage caused by each of these substances as well as the stability of 
these formulations when exposed to UV radiation. 
It is important to note that this approach can also be used to reveal whether a UV-
absorbing ingredient is non-phototoxic or has the potential to transfer energy to other 
molecules in a formulation to induce toxic effects (Institute for in vitro Sciences, 2013). 
Although the 3D skin models are generally designed to simulate the epidermis or 
the full human skin, none is currently approved for testing of skin absorption, an 
important point when we evaluated toxic effects (Abd et al, 2016). Nevertheless, these 
models are important tools for performing screening tests and thereby reducing animal 
experiments. 
 
Evaluation of formulations – degradation process 
 
UV-vis spectrophotometry analyses revealed that the formulation samples without 
sunscreen (basic formulation - Formulation 1) underwent a change in their absorption 
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spectra when subjected to irradiation (without aluminum foil protection) in the 
photostability chamber. This is easily seen in the formulation absorption peak due to the 
alteration of the peak intensity at λ = 227 nm, with absorbance of 0.9939 and 0.7984 for 
irradiated and protected formulations, respectively (Figure 2A). 
It is also clear that this change observed in the emulsified system does not 
interfere with the main absorption peaks of the sunscreens. In fact, for both formulations 
– AVB (Formulation 3) whose absorption peak is at 357 nm and for OMC (Formulation 
2) with a peak at 307 nm – there is no influence of the basic formulation absorption 
spectrum. 
The comparison of the absorption spectra of the irradiated and protected AVB 
formulations showed a clear change in the sunscreen due to the exposure to light, which 
is indicative of photodegradation. This fact can be verified by the significant reduction 
in absorbance at 357 nm (0.4060 to 0.1573) and increased absorbance at a secondary 
wavelength peak of 271 nm (0.1469 to 0.2276) (Figure 2B). 
On the other hand, after irradiation, OMC showed no significant change in its 
absorption spectrum for the basic formulation compared to the protected formulation. 
For this sunscreen, the characteristic peak at 307 nm had absorbance values of 0.8300 
and 0.8092 for the protected and irradiated formulations, respectively. Further, it is 
possible to attest that the sunscreen absorption spectra substantially overlap, being 
indicative of the OMC absorptivity maintenance in the analysis media, suggesting the 
maintenance of sunscreen structure (Figure 2C). 
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Fig. 2. UV-vis absorption spectra after UVA exposed in photostability chamber for the 
three formulations covered (C) and not covered (NC). A- Basic formulation (BF); B- 
AVB formulation (AVB), C- OMC formulation (OMC); The concentration of all 
formulations in ethanol for UV-vis assay was 0.04 mg/mL. 
Photodegradation and toxicity using skin models – cellular viability assessment 
 
A testing strategy was developed to minimize the number of cultures required, 
being the toxicity assessed in the dark (NI: not irradiated) and the phototoxicity assessed 
in the light (I: irradiated). 
A 
B 
C 
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Based on the results achieved with the permanence of skin models (n=4) only in 
PBS (NT: no-treatment, not submitted to photodegradation in a photostability chamber) 
for each situation (NI and I), we concluded that the skin model had suitable viability 
and sensitivity for this test (Table 4). The skin models that were treated with PBS and 
left in the dark (NI) had absorbance values greater than 1.0, while the absorbance values 
became slightly lower in the presence of UV light (0.9). This indicates that the skin 
model was capable of detecting the influence of UV radiation on cell viability - a 
finding already pointed by Chatelain and Gabard (2001). 
Using the t-test it was possible to assess that there is no statistical difference 
between the replicates of all the conditions evaluated, showing that the test is 
reproducible. We also showed a statistically significant difference (p = 2.61 x 10
-5
) 
between the irradiated samples and those without irradiation (NI) in the phototoxicity 
control test with PBS only, demonstrating the appropriate functioning of the 
phototoxicity chamber. 
Since the skin model incorporates a well-formed epidermis (after 21 days of 
cultivation in an air-liquid interface), it has the necessary feasibility to test complete 
formulations, such as oil-in-water based creams for phototoxic potential. Also, due to 
the 3-D structure, the formulations could be adequately spread on the culture without 
damaging the surface. The formulations were made in the same way as commercial 
sunscreens and tested without dilution to mimic usage concentrations. All formulations 
were divided in two groups for testing: with or without prior radiation in the 
photostability chamber. 
One-way analysis of variance (ANOVA one-way) of cell viability results of 
formulations covered with aluminum foil (Table 2) showed significant difference (p = 
6.4 x 10
-28
). Duncan’s post-hoc test (Table 2), was then applied to these data to evaluate 
which cell viability means (%) were statistically different from each other. Formulations 
covered with aluminum foil containing OMC or AVB (OMC/C/I, OMC/C/NI, AVB/C/I 
and AVB/C/NI) showed lower cell viability than control formulations (BF/C/I, 
BF/C/NI) and PBS (PBS/I and PBS/NI) independently of UVA exposure (I or NI). Cell 
viability from formulations subjected to UVA photodegradation without aluminum foil 
(Table 3) also showed significant difference (p = 8.2 x 10
-24
) and Duncan’s test was also 
applied to the data. The values of cell viability from formulations containing OMC or 
AVB (OMC/NC/I, OMC/NC/NI, AVB/NC/I and AVB/NC/NI) were lower than those 
from control formulations (BF/C/I, BF/C/NI) and PBS (PBS/I and PBS/NI) (Table 3). 
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The toxicity (low cell viability values) found for the three formulations (BF, OMC and 
AVB) can be related to their own formula components, especially AVB and OMC 
filters that exhibited lower cell viability values, when compared to PBS control (100% 
cell viability). 
 
Table 2. Clusters of the formulations covered with aluminum foil (C) and PBS 
according to Duncan’s test in six groups of cell viability means (%). BF: basic 
formulation; AVB: basic formulation with AVB; OMC: basic formulation with OMC; 
C: covered with aluminum foil when submitted to photostability chamber; I: irradiated; 
NI: not irradiated; PBS: phosphate buffer solution.   
 
Formulation Cell viability 
mean (%) 
1 2 3 4 5 6 
AVB/C/NI 62.11 ****      
OMC/C/I 65.03  ****     
AVB/C/I 65.47  ****     
OMC/C/NI 71.57   ****    
BF/C/I 73.74   ****    
BF/C/NI 79.08    ****   
PBS/I 84.95     ****  
PBS/NI 100.05      **** 
The groups represent clusters of cell viability means (%) grouped according to their similarities. 
Considering p < 0.05, there are significant differences between means in different groups and there are no 
significant differences between means in the same group. 
 
Table 3. Clusters of the formulations without aluminum foil (NC) and PBS according to 
Duncan’s test in five groups of cell viability means (%). BF: basic formulation; AVB: 
basic formulation with AVB; OMC: basic formulation with OMC; NC: not covered 
with aluminum foil when submitted to photostability chamber; I: irradiated; NI: not 
irradiated; PBS: phosphate buffer solution. 
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Formulation Cell viability 
mean (%) 
1 2 3 4 5 
AVB/NC/I 63.17 ****     
AVB/NC/NI 72.74  ****    
OMC/NC/I 80.39   ****   
OMC/NC/NI 81.14   ****   
BF/NC/I 82.44   **** ****  
BF/NC/NI 84.44    ****  
PBS/I 84.95    ****  
PBS/NI 100.05     **** 
The groups represent clusters of cell viability means (%) grouped according to their similarities. 
Considering p < 0.05, there are significant differences between means in different groups and there are no 
significant differences between means in the same group. 
 
It is important to highlight that the toxicity exhibited in dark conditions (UVA
-
) 
by the three formulations (BF, OMC and AVB) when photodegraded could indicate that 
the sun filters and their formulations are inherently toxic to the skin model cells in the 
dark, although the actual mechanism of this toxicity remains unclear. The results 
showed higher cell viability in skin models exposed to UVA radiation (BF/NC/I, 
BF/NC/NI, OMC/NC/I, OMC/NC/NI, AVB/NC/I and AVB/NC/NI) compared to those 
that were protected from radiation in photodegradation chamber (BF/C/I, BF/C/NI, 
OMC/C/I, OMC/C/NI, AVB/C/I and AVB/C/NI) as shown in Table 4. 
High cell viability presented by all photodegraded formulations (i.e. those that 
underwent prior radiation – BF/NC/I, BF/NC/NI, OMC/NC/I, OMC/NC/NI, AVB/NC/I 
and AVB/NC/NI, shown in Table 4) and formulations which underwent two radiation 
exposures indicates that some formulation ingredients were inactivated by exposure to 
UV radiation. Formulations that received two radiation processes (I) presented cell 
viability of 82.44% (BF/NC/I), 80.39% (OMC/NC/I) and 63.17% (AVB/NC/I), 
suggesting that AVB is more unstable and toxic than OMC. This reinforces the idea that 
a long period of photodegradation in sunscreens by UV radiation can result in less 
toxicity and even phototoxicity when compared to formulations/sunscreens that did not 
receive any UV radiation or remained in the dark. 
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It is already known that chemical sunscreens have the capability to absorb UV 
light and this ability can generate adverse effects. Once a sunscreen molecule absorbs a 
UV photon, it is raised to an excited state and can eventually release the absorbed 
energy in the form of lower energy photons that are free to interact with other 
molecules. Such effects are called secondary effects, and can lead to the creation of free 
radicals that may cause irritation and damage to skin (Benson, 2000; Herrling et al., 
2007). 
Our results indicate that the existence of photoproducts of AVB could lead to an 
increase in cell death in the skin models. However, there is an increase in cell death 
when the formulations/sunscreens are exposed to UV radiation only once (BF/C/I, 
BF/C/NI, OMC/C/I, OMC/C/NI, AVB/C/I and AVB/C/NI), when compared to 
formulations/sunscreens exposed twice (BF/NC/I, BF/NC/NI, OMC/NC/I, 
OMC/NC/NI, AVB/NC/I and AVB/NC/NI), as shown in Table 4. After the degradation 
process and UVA exposure of the formulations/sunscreens applied on the skin models, 
this effect appears to be reduced, which possibly indicates the breakdown of primary 
reactive photoproducts to less reactive photoproducts. 
However, if the testing of a formulation like a sunscreen as-supplied is needed, it 
could be interesting and even required to test through a reduced pre-incubation time, the 
photodegradation as in this study, or investigate their component substances on a case-
by-case basis, and its impact in toxicity tests. Nevertheless, the three formulations were 
not found to be overtly toxic, although all show toxicity to a greater or lesser extent, 
which might be expected when a chemical is directly applied and maintained for many 
hours on the skin. All the statistics comparation were plotted at Table 4.  
 
Table 4.  The statistic comparison of all formulations and treatments. 
Formul
ation 
BF OMC AVB 
Photod
egradat
ion 
 Photodegraded  Photodegraded  Photodegraded 
Treatm
ent 
NT C NC NT C NC NT C NC 
Irradiat
ion 
I N
I 
I N
I 
I N
I 
I NI I NI I NI I NI I NI I NI 
Formul B B B B B B O O O O O O A A A A A A
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ations/ 
Treatm
ent/ 
Irradiat
ion 
F/ 
N
T/ 
I 
 
F/ 
N
T/ 
N
I 
F/ 
C/ 
I 
F/ 
C/ 
N
I 
F/ 
N
C/ 
I 
F/ 
N
C/ 
N
I 
M
C/ 
N
T/ 
I 
M
C/ 
N
T/ 
NI 
M
C/ 
C/ 
I 
M
C/ 
C/ 
NI 
M
C/ 
N
C/ 
I 
M
C/ 
N
C/ 
NI 
V
B/ 
N
T/ 
I 
V
B/ 
N
T/ 
NI 
V
B/ 
C/ 
I 
V
B/ 
C/ 
NI 
V
B/ 
N
C/ 
I 
V
B/ 
N
C/ 
NI 
% Cell 
viabilit
y 
66
.0
6 
67
.2
1 
73
.7
5 
79
.0
9 
82
.4
4 
84
.4
4 
78
.0
9 
76
.5
2 
65
.0
4 
71
.5
7 
80
.3
9 
81
.1
5 
58
.8
3 
82
.9
1 
65
.4
7 
62
.1
1 
63
.1
7 
72
.7
5 
SD 3.
23 
2.
19 
3.
14 
1.
80 
2.
23 
3.
19 
2.
18 
1.
66 
1.
52 
1.
52 
1.
25 
1.
59 
0.
93 
0.
70 
1.
86 
1.
39 
2.
56 
1.
95 
t-test 
p-value 
= 
p = 
0.244 
≠ 
p = 
0.002 
= 
p = 
0.118 
= 
p = 
0.095 
≠ 
p = 
1.09x10
-5
 
= 
p = 
0.189 
≠ 
p = 
1.04x10
-13
 
≠ 
p = 
0.002 
≠ 
p = 
1.33x10
-5
 
BF: basic formulation; OMC: basic formulation with OMC; AVB: basic formulation with AVB; 
Photodegraded: submitted to photodegradation in a photostability chamber; NT: no-treatment (not 
submitted to photodegradation in a photostability chamber); C: covered with aluminum foil; NC: not 
covered with aluminum foil; I: irradiated (submitted to UVA radiation in a phototoxicity chamber); NI: 
not irradiated (not submitted to UVA radiation in a phototoxicity chamber); = without significant 
difference (p > 0.05); ≠ with significant difference (p < 0.05)  
A t-test was used to assess the statistical differences between the average cell 
viabilities with samples exposed to UVA radiation in the phototoxicity chamber. In the 
presence of AVB, with (AVB/NC) or without (AVB/C) photodegradation, there was no 
statistically significant difference in cell viability between irradiated (AVB/NC/I and 
AVB/C/I) and non-irradiated (AVB/NC/NI and AVB/C/NI) samples (Table 4).   
In the base formulation and the formulation with OMC there were significant 
differences between irradiated and non-irradiated forms for those subjected to 
photodegradation protected with aluminum foil (Table 4). 
Cell viability evaluation described in Table 4 were obtained using one-way 
ANOVA, and the statistic difference found (p = 1.18 x 10
-49
), was taken considering 
significant p < 0.05. Tukey test was used to show the differences among the data 
analyzed (Table 5). 
 
Table 5. Clusters of formulations in nine groups according to average cell viability 
using Tukey test. There is no significant difference (p < 0.05) between means in the 
same group. BF: basic formulation; AVB: basic formulation with AVB; OMC: basic 
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formulation with OMC; NC: not covered with aluminum foil when submitted to 
photostability chamber; I: irradiated; NI: not irradiated; PBS: phosphate buffer solution. 
 
Formulations Cell 
viability 
mean 
(%) 
1 2 3 4 5 6 7 8 9 
AVB/NT/I 58.83 ****         
AVB/C/NI 62.11 **** ****        
AVB/NC/I 63.17  **** ****       
OMC/C/I 65.04  **** ****       
AVB/C/I 65.47  **** ****       
BF/NT/I 66.06  **** ****       
BF/NT/NI 67.21   ****       
OMC/C/NI 71.57    ****      
AVB/NC/NI 72.75    **** ****     
BF/C/I 73.75    **** ****     
OMC/NT/NI 76.52     **** ****    
OMC/NT/I 78.09      **** ****   
BF/C/NI 79.09      **** ****   
OMC/NC/I 80.39      **** **** **** **** 
OMC/NC/NI 81.15       **** **** **** 
BF/NC/I 82.44        **** **** 
AVB/NT/NI 82.91        **** **** 
BF/NC/NI 84.44         **** 
 The groups represent clusters of cell viability means (%) grouped according to their similarities. 
Considering p < 0.05, there are significant differences between means in different groups and there are no 
significant differences between means in the same group. 
 
Tukey test (Table 5) showed the mean cell viability of the formulations was 
distributed into nine groups for the different samples and their treatments. BF without 
photodegradation (no-treatment) – formulations BF/NT/I and BF/NT/NI (group 3) – 
presented a high level of cytotoxicity, however, this effect remains equal for irradiated 
and non-irradiated formulations. Also, it is important to highlight that the cytotoxicity 
of the BF without photodegradation (no-treatment) was higher than the OMC-
containing formulations (OMC/NT/I and OMC/NT/NI) in groups 5, 6 and 7. This 
finding suggests that the sunscreen may at least be exerting a protective action against 
the toxicity exerted by the components of the base. In addition, the OMC did not suffer 
degradation as shown in the spectra (Figure 2C), probably due to its photoprotector 
characteristic whose spectrum of action is due to UVB radiation, therefore out of 
photodegradation range applied in this study.  
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In general, when formulations containing AVB (AVB/NT/I, AVB/C/I, AVB/C/NI 
and AVB/NC/I) were subjected to different treatments, lower cell viability was shown 
(Groups 1, 2 and 3 in Table 5). However, the same formulations containing AVB with 
no-treatment (AVB/NT/NI) and not exposed to UVA (Group 8, Table 5) showed lower 
levels of cytotoxicity. This result shows the importance of testing formulations 
containing AVB in real conditions of use, i.e., how the consumer will in fact be 
exposed. The test formulations without that simulation can generate false-negative 
results in safety tests. This can be extended to other topical formulations.  
 These finding were also corroborated by Briasco et al. (2017) in a study of the 
stability of a sunscreen product packed in a LDPE/HDPE mixture, simulating the 
possible stress conditions that solar products could meet during their “real in-use” life. 
Their results confirm the importance of studying all aspects related to the final product, 
as they stress the conditions that sunscreen products are exposed to could affect both 
quality and safety of the product. 
 
Histological analysis of the reconstructed skin model 
 
After the cytotoxicity and phototoxicity tests, the skin models were sectioned, and 
HE stained, in order to assess their structural conditions after application and removal of 
formulations with OMC (Fig. 3, B1 - B2) and AVB (Fig. 3, C1 - C2) when compared to 
PBS (Fig. 3, A1 - A2). 
Figure 3 shows no evidence of abrasive or deconstructive effects on the skin 
model epidermis, regardless of whether they were treated with the formulations or 
immersed in PBS. The same result can be seen in the presence (I) and absence of 
radiation (NI). 
Some cellular disorganization was observed in a couple of analyzed skin models, 
in spite of the presence of a confluent and stratified epithelium. This may be explained 
by the loss of the undifferentiated basal keratinocytes that were not retained on the 
dermal scaffolds due to loosening of collagen fibers that formed their base. This was 
most likely caused by the prior 50 kGy irradiation used for sterilization of the acellular 
dermis used as a scaffold to keratinocytes and fibroblasts growth. In future experiments, 
sterilization of these dermis scaffold will be performed at 25 kGy to prevent the loss of 
some of these binding cells for an improved composition of the skin model. 
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Ponec et al. (2001) studied the barrier function in a reconstructed epidermis model 
very similar to the one used here. They reported that the formation of the stratum 
corneum (SC) barrier in vitro proceeds similarly as in vivo, as judged from the extensive 
production of lamellar bodies, and the formation of multiple lamellar structures in the 
intercorneocyte space. In fact, all the construction process to obtain the skin model, 
mimics the in vivo process, with the exposure of the keratinocytes to air/liquid 
environment, to guarantee the differential process of keratinocytes to corneocytes and 
consequentially the stratum corneum formation. 
The stratum corneum formation in our skin model is illustrated in the histological 
photomicrography in Figure 3. In addition, in our study the AVB and OMC 
formulations remained in contact with the skin model for only two hours, during which 
time significant permeation is unlikely to occur. As described by Yang et al. (2008) a 
formulation containing AVB showed very low permeation, as required of UV-absorbing 
agents such as both AVB and OMC that must remain in the outermost layer of the skin 
to be effective. 
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Fig. 3. Evaluation of the integrity of the skin models employed in the tests. Control 
group PBS (A1 – PBS/C/I and A2 – PBS/C/NI) and groups tested using formulations 
with OMC (B1 – OMC/C/I and B2 – OMC/C/NI) and AVB (C1 – AVB/C/I and C2 – 
AVB/C/NI). Optical microscopy (HE). Original magnification 100X. 
 
4. Conclusions 
 
An in vitro three-dimensional human skin model was developed and used to 
assess the phototoxicity resulting from application of sunscreens and their oil-in-water 
formulations. This skin model could overcome the need for in vivo animal testing, at 
least in the early stages of testing of currently marketed sunscreens, but also for new 
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formulations and other innovations in photoprotection, as a partial replacement test, 
within a tiered testing strategy. The development of photoprotectors containing organic 
products is a considerable challenge to the formulator due to the inherent instability of 
certain filters. Most substances used as UV filters are photoreactive. 
The permanence of skin models only in PBS in dark and light conditions shows 
the skin model’s ability to accurately assess the influence of UV radiation on cell 
viability. When considering the topical application of sunscreens, the results showed a 
lower toxicity in all formulations/conditions tested, even in the control formulation (BF) 
when compared to PBS. 
This reinforces the concept that a long period of photodegradation by UV 
radiation can result in less toxicity and even phototoxicity when compared to 
formulations/sunscreens that were not  exposed to UV radiation or remained in the dark. 
This indicates that the sun filters and their formulations are inherently toxic to the skin 
model cells in the dark; however, the mechanism of this toxicity remains unclear. 
The combination of results presented in this work indicates that the in house in 
vitro skin model can be used as a reference for future testing of toxicity in different 
kinds of cosmetic and drug formulations. 
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HIGHLIGHTS 
 Skin models can evaluate the potential phototoxicity of sunscreens; 
 The importance of testing sunscreen formulations in real consumer use conditions; 
 Suitable alternative to animal models for phototoxicity tests; 
 Photodegradation and phototoxicity radiation could eliminated intermediate products; 
 Most substances used as UV filters are photoreactive. 
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